Company
Science
Products
Animals
메뉴를 선택하세요.
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
메뉴를 선택하세요.
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
CLOSE
R & D
Patients
Veterinarians
IR
Jobs
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
News
> IR > News
News
Events
Report
제목
대웅제약·플럼라인·박셀바이오, 반려동물 전용 의약품 개발 봇물
작성자
관리자
등록일
22-05-17
조회수
3,145
플럼라인생명과학 측은 "나이가 들수록 면역세포인 T세포 수가 감소하므로 면역력 감소, 근육 감소 등의 노화 현상이 발생한다"면서
"시험약은 강아지 몸 속에서 정상적으로 분비되는 호르몬을 적절한 농도로 방출하게 해주는 물질로,
면역세포 수를 증가시켜 면역력 증진, 활동량 및 식욕 개선 등의 효과를 낼 수 있다"고 설명했다.
https://www.ceoscoredaily.com/page/view/2022051116173468455
목록
공지사항
이전글
플럼라인생명과학, 아프리카돼지열병 백신 러브콜 ‘속속’...기술우위 '한몫'
공지사항
다음글
반려견 DNA면역항암제'PLS-D5000' 3상 계획 승인